Ayreen

Medicinal product

(Invented) name

Ayreen

Active substance (s)

Dienogestas/Etinilestradiolis

Strength

2 mg/0,03 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AA16, Dienogest and ethinylestradiol

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-10-23

Date of renewal

Documents

2969_Ayreen 2mg_0,03mg_pl_deng_tab_PL_2025-10-23.docx

2969_Ayreen 2mg_0,03mg_pl_deng_tab_PZ_2025-10-23.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dienogestas	2 mg
Etinilestradiolis	0,03 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118979	105085	1105085	lizdinė plokštelė	N3x21		Receptinis	LT/L/25/2969/001	Netiekiama	-	2026-01-02	No	-	-	Download

Stadijos

Data	Stadija
2025-10-23	Registruotas